Caplight Directory>Companies>Relavo-preview>Relavomedical


Relavo

Private
Baltimore, MarylandHealthcare & Life Sciences

Last Round

Seed

May 1, 2024

Total Funding Raised

$2.54M

Company Overview

Relavo is a medical device company developing the PeritoneX, a device that disinfects dialysis tubes to reduce the risk of infection for patients undergoing at-home peritoneal dialysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

peritoneal dialysisPDhome dialysisperitonitis preventionmedtechinfection preventionend-stage renal diseaseESRDdialysis suppliesdisinfecting devicekidney failuredialysis technologymedical disposablesrenal careFDA Safer Technologies Program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Relavo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Relavo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2024
GrantApr 26, 2022
Pre SeedAug 26, 2020
GrantAug 3, 2020
View all Funding Rounds

Relavo Investors

Notable investors and investment history

InvestorRounds
Citrine AngelsSeed
FastForward UPre Seed
New York VenturesSeed
San Diego Angel ConferenceSeed
National Kidney FoundationSeed
National Science FoundationGrant
View all Investors

Relavo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Relavo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Relavo's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Year Founded2018
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.